UBS AM’s Turning Point Therapeutics, Inc. Common Stock TPTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q3 | – | Sell |
-48,759
| Closed | -$3.67M | – | 2796 |
|
|
2022
Q2 | $3.67M | Buy |
48,759
+4,796
| +11% | +$361K | ﹤0.01% | 1331 |
|
|
2022
Q1 | $1.18M | Hold |
43,963
| – | – | ﹤0.01% | 2048 |
|
|
2021
Q4 | $2.1M | Sell |
43,963
-946
| -2% | -$45.1K | ﹤0.01% | 1857 |
|
|
2021
Q3 | $2.98M | Buy |
44,909
+322
| +0.7% | +$21.4K | ﹤0.01% | 1645 |
|
|
2021
Q2 | $3.48M | Buy |
44,587
+2,149
| +5% | +$168K | ﹤0.01% | 1569 |
|
|
2021
Q1 | $4.01M | Buy |
42,438
+5,777
| +16% | +$546K | ﹤0.01% | 1432 |
|
|
2020
Q4 | $4.47M | Buy |
36,661
+8,300
| +29% | +$1.01M | ﹤0.01% | 1343 |
|
|
2020
Q3 | $2.48M | Sell |
28,361
-722
| -2% | -$63.1K | ﹤0.01% | 1460 |
|
|
2020
Q2 | $1.88M | Buy |
29,083
+19,583
| +206% | +$1.26M | ﹤0.01% | 1541 |
|
|
2020
Q1 | $424K | Sell |
9,500
-5,178
| -35% | -$231K | ﹤0.01% | 2034 |
|
|
2019
Q4 | $914K | Buy |
+14,678
| New | +$914K | ﹤0.01% | 1957 |
|